and it is less than 15 mm right now. 10X upside imo.
Seems like several insider purchases and investments by professional athletes.
22 Million is penny's for the big dogs. Some of which do not have 4 FDA approved products either.
One would think they would get a significant bump in business and also get put on the map in relations to visibility.
I am that confident is what I am hearing about the new FDA approvals and sales strategy. Going to be a serious player in the diagnostic space very soon.
upside is far greater than downside now. Just went long myself. 21K
GBSN is only 12 million market cap. Should be at least 100 million.